Polatuzumab for Named Patient Import

Polatuzumab for Indian Patients

Polatuzumab is one of the latest FDA drug approved for the therapeutic management of diffuse large B-cell lymphoma, in specific settings. It’s an innovation of Roche, a company credited for developing many Oncology and Haematology drugs. This drug is accessible as Polivy, its commercial name. Mostly available in the European and US markets, the benefits of this medication are significantly prominent.

Polatuzumab or Polivy in India is not available for active distribution and patient supplies. Polivy 140mg Vials are accessible from the global markets with prior statutory approvals. For Indian Patients, the best way of procuring Polatuzumab is by availing Named Patient Import Permit. This amounts to legal sourcing and in line with the statutory provisions of medicine imports.

Polatuzumab in India? Allow us to help.

When patients in India are recommended to use medications that are not available from domestic sources, we will pitch in with our services. Our proven track record stands to our credit in this segment. We will support you with everything that matters, from documentation to the actual procurement. The authentic sources we endorse are not only licensed, but also have prior experience of handling imports of medicines such as Polatuzumab or Polivy.

Email at nhs@noelbiotech.com or call us on + 91 9677010046 / + 91 9929277766.